Loading Events

COVID-19 & The Kidneys

Thank you for attending, we hope you enjoyed this webinar.

Please tell us what you thought about today’s presentation by taking the survey below:

COVID-19 & The Kidneys

Acute kidney injury has been associated with an increased mortality rate among hospitalized patients with COVID-191 and there is evidence to support an increased risk of mortality and hospitalization in patients with chronic kidney disease2. In this webinar, Dr. Yongen Chang discusses the currently known pathophysiology of COVID-19 and important considerations in the care of patients with kidney disease.


  1. Sabaghian et al. COVID-19 and Acute Kidney Injury: A Systematic Review. Front Med. 2022: 1-9
  2. Jdiaa et al. COVID–19 and chronic kidney disease: an updated overview of reviews. Journal of Nephrology. 2022. 35:69–85


Yongen Chang

Yongen Chang, MD

Assistant Professor Division of Nephrology, Hypertension and Kidney Transplant Department of Medicine

UC Irvine*

Dr. Chang is board certified in internal medicine and nephrology, and is a fellow of the American Society of Nephrology (FASN). She completed nephrology fellowship training at the University of California, San Francisco, and PhD studies at Cornell University. Since her time at UCSF and Cornell, Dr. Chang has conducted translational research in kidney fibrosis and integrin biology, and was awarded the prestigious Ben J. Lipps Research Fellowship from the American Society of Nephrology and Ruth L. Kirschstein National Research Service Award from the National Institute of Health. She has published in many high impact, peer-reviewed journals and has written several book chapters based on her work. In addition to research, Dr. Chang is also a dedicated, experienced clinician educator with expertise in continuous kidney replacement therapy, glomerulonephritis, and kidney diseases in pregnancy and malignancy. She has served as the nephrology fellowship training program director and medical director of the inpatient dialysis services at the University of California, Irvine. She is also a regular contributor to the journal Renal and Urology News.

Jaimini Patel

Jaimini Patel, PharmD, BCCCP

Nephrology Medical Science Liaison

Otsuka Pharmaceutical Development & Commercialization, Inc.*

Jaimini Patel, PharmD, BCCCP, is a Nephrology Medical Science Liaison at Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC). Dr Patel earned her Doctorate in Pharmacy from the University of Michigan, Ann Arbor and completed two years of post-doctoral residency at Beaumont Hospital, Royal Oak and Loyola University Medical Center, respectively, specializing in critical care pharmacy practice. Prior to joining Otsuka, Dr Patel practiced as a critical care pharmacist at the Cleveland Clinic Akron General Medical Center for 3.5 years and has cared for patients in the medical, surgical/trauma, cardiothoracic and neuroscience ICUs, and was significantly involved in the care of patients with COVID-19. Dr Patel holds board certification in critical care pharmacotherapy and is a licensed pharmacist in Michigan, Illinois and Ohio. She is also an active member of the Society of Critical Care Medicine through which she is engaged in research and leadership.

*Dr Chang is a paid consultant of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC). Dr Patel is an employee of OPDC.


Related Resources

Join Today for Instant Access to all NephU Offerings.

Membership is free!

Join NephU today at no cost to register for this event and access to other premium content.

  • The NephU Community is collaborating to improve care and the future outcomes for individuals with kidney disease and other related conditions.
  • Quickly learn more about the topics that interest you.
  • Access our library of on-demand kidney health resources
  • Gain key insights from industry experts & though leaders.